There is an association between being overweight, abdominal obesity, and a high body fat percentage with a greater risk of rheumatoid arthritis (RA) for women but not men, according to a study.
There is an association between being overweight, abdominal obesity and a high body fat percentage with a greater risk of rheumatoid arthritis (RA) for women but not men, according to a study.
Women with a body mass index (BMI) of 25-29.99 kg/m2 are considered overweight, while those with a BMI greater than 30kg/m2 are considered obese. Abdominal obesity in women is defined by a waist circumference that is greater than 88 centimeters.
“One possible explanation for these inconsistencies is that while BMI has been the preferred surrogate measure for being overweight in these studies, BMI only correlates modestly with total amount of body fat and does not accurately reflect fat distribution,” said lead author Dr Asta Linauskas from University Hospital, Aarhus, Denmark, according to a press release from the Annual European Congress of Rheumatology, where the findings were presented.
Of the 54,284 study participants, 52% were female between the ages of 50 and 64. Over the 21-year follow-up period, 283 women and 110 men had developed RA. The study notes that there is not an association between overweight men and RA development due to the different criteria that determine the weight categories.
When a statistical analysis was performed to investigate the link between body fat percentage and RA risk in women, the “restricted cubic spline” analysis demonstrated a positive slope, representing a direct relationship; however, no association could be confirmed for men.
“Our results support an association between the risk of developing RA and three different criteria for being overweight or obese in women. We believe RA should be included in the list of all the other medical conditions linked to obesity. It would certainly make sense for women with a family history of RA to try to avoid becoming overweight,” concluded Linauskas.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More